Vexim SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Edison Investment Research
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Vexim SA Continues to Develop Its Business Across Europe by Setting up an Italian Subsidiary
Vexim SA announced its incorporation of an Italian subsidiary (in Milan). Vexim already has a strong reputation in Italy and so creation of this subsidiary will help accelerate the commercial development of the company's flagship SpineJack product range on Italian soil.
Latest Developments for Vexim SA
- Vexim SA announces results of study of SpineJack
- Vexim SA Announces Results of Retrospective Study of SpineJack
- Vexim SA Announces Preliminary Results of International Clinical Study on Performance of SpineJack in Treating Vertebral Fractures
- CLINICAL BIOMECHANICS Publishes Study Proving Positive Performance of Vexim SA's SpineJack-DJ
Latest Key Developments in Medical
- Share this
- Digg this